Table of Contents Table of Contents
Previous Page  7 / 280 Next Page
Information
Show Menu
Previous Page 7 / 280 Next Page
Page Background www.horizon2020projects.com

H O R I Z O N 2 0 2 0 P R O J E C T S : P O R TA L

I S S U E S E V E N

7

SOCIETAL CHALLENGES

124

SOCIETAL CHALLENGES: HEALTH & WELLBEING

124

THE NEW ELDERLY

European Commissioner Carlos Moedas outlines the value of R&I and partnerships to overcoming the difficulties of an ageing EU population

ROADS TO RESILIENCE

126

Following the Germanwings tragedy in March, Pfalzklinikum’s Paul Bomke says that mental health issues require a multiagency,

preventive approach. He identifies the importance and significance of resilience as a skill needed to cope with changes and the

difficulties that are faced in life, as well as providing details on the ‘Roads to Resilience’ initiative

PROFILE:

The Age Institute promotes good ageing by implementing evidence-based health promotion

127

INNOVATIONS FOR BETTER HEALTH

128

The interim chief executive of EIT Health, Dr Ursula Redeker, updated Portal on the latest progress in developing the Knowledge and

Innovation Community. At INNOVEIT 2015 in Budapest, she detailed how the KIC aims to meet ambitious goals by 2018, how each

consortium partner voice will be heard, and how EIT Health will draw its funding from across Europe

PROFILE:

The Pain Pathophysiology Lab searches for an effective, preventive strategy to slow osteoarthritis progression

130

PROFILE:

The School of Pharmacy and Biomedical Science explains why 3D printers could change the way we make tablets

132

ADVOCATING AMR ACTION

135

Tackling antimicrobial resistance (AMR) is a central theme of a patient safety report by Italian MEP Piernicola Pedicini. In an interview,

Portal investigated further with the Member of the European Parliament the barriers the EU is facing in tackling AMR, the key aims and

proposals of his ‘Safer healthcare in Europe’ report, and what further action can be taken

PROFILE:

The Department of Biology at Northeastern University explains why access to ‘missing’ microbial diversity is essential

138

BONE BREAKTHROUGH

140

The University of Sheffield’s Professor Paul Hatton spoke to Portal about taking a breakthrough in tackling bone infection to market

PROFILE:

The Laboratory for Muscle Plasticity is constantly exploring and researching in its quest to perfect muscle function

144

CANCER & CARDIOVASCULAR DISEASE

146

UNEXPECTED DISCOVERY

Benefitting from a five-year Consolidator Grant from the European Research Council, Dr Laura Soucek of Spain’s Vall d’Hebron Institute

of Oncology spoke to Portal about the great potential of Omomyc, a breakthrough for the Myc field. Following the development, she

detailed the possibility of extensively tackling cancer and the subsequent creation of a drug

A NEW TREATMENT

148

Speaking to Lydie Meheus, the managing director of the Anticancer Fund, Portal explored the use of, and barriers to, non-mainstream treatments

PROFILE:

The Anticancer Fund, Belgium, is dedicated to expanding the range of treatment options available to patients

149

THE BIOLOGY OF CVD

150

Portal details cardiovascular disease biology and a move by the EMA to recommend the authorisation of Repatha to help lower cholesterol

PROFILE:

Biozentrum der Universität Basel works to understand the formation and remodelling of blood vessels on the cellular level

152

METABOLIC DISEASES

154

A RESPONSE TO TYPE 2 DIABETES

Portal spoke to Public Health England’s Professor Kevin Fenton on how the country is moving to tackle the diabetes epidemic

PROFILE:

The Clore Laboratory, University of Buckingham, speculates on the role of brown fat in fighting metabolic disease

158

LIVER PIONEER

160

Portal outlines a new Horizon 2020 project to diagnose and treat non-alcoholic fatty liver diseases led by the UK’s Newcastle University

PROFILE:

Palacky University, Olomouc, is at the leading edge of research and screening to aid in the diagnosis of metabolic disorders

162

INDUSTRIAL LEADERSHIP (continued)

116

BIOBANKING BENEFITS

116

Cell & Co spoke to Portal about the development of biobanking, benefits to research, overcoming obstacles, and the role of Horizon 2020

BIOTECHNOLOGY FOR HEALTH

118

INTO THE BLUE

Blue biotechnology has dramatic potential to boost blue growth, as Portal found out

PROFILE:

Researchers at the Ryan Institute, Galway, are discovering priceless resources in the Atlantic

121

PROFILE:

The Department of Pharmacology at the USC uses common signalling links to propose new drugs and advance in seafood safety

122

©KatherinWermke

©EuropeanUnion2014 - source:EP